Login / Signup

Therapeutic potential of PPARγ natural agonists in liver diseases.

Liwei WuChuan-Yong GuoJianye Wu
Published in: Journal of cellular and molecular medicine (2020)
Peroxisome proliferator-activated receptor gamma (PPARγ) is a vital subtype of the PPAR family. The biological functions are complex and diverse. PPARγ plays a significant role in protecting the liver from inflammation, oxidation, fibrosis, fatty liver and tumours. Natural products are a promising pool for drug discovery, and enormous research effort has been invested in exploring the PPARγ-activating potential of natural products. In this manuscript, we will review the research progress of PPARγ agonists from natural products in recent years and probe into the application potential and prospects of PPARγ natural agonists in the therapy of various liver diseases, including inflammation, hepatic fibrosis, non-alcoholic fatty liver and liver cancer.
Keyphrases
  • insulin resistance
  • fatty acid
  • drug discovery
  • oxidative stress
  • type diabetes
  • nitric oxide
  • risk assessment
  • human health
  • mesenchymal stem cells
  • cell therapy
  • single molecule